Evidence map›Paper›PMID 37822451›Full record

ArticleMaterials today. Bio2023

Enhancing the sensitization of neuroblastoma to radiotherapy by the construction of a dual-channel parallel free radicals nanoamplifier.

Wenxin Zhang, Xiaodie Li, Jialin Zeng, Xin Wen, Chao Zhang, Yinan Zhang, Jian He, Lihua Yang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Wenxin ZhangDepartment of Pediatric Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, 510282, China.
Xiaodie LiDepartment of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, 510282, China.
Jialin ZengDepartment of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, 510282, China.
Xin WenClinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, China.
Chao ZhangDepartment of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, 510282, China.
Yinan ZhangSchool of Chemical Science and Engineering, Tongji University, Shanghai, 200092, China.
Jian HeDepartment of Nuclear Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China.
Lihua YangDepartment of Pediatric Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, 510282, China.
Zhujiang Hospital · CNNanjing Drum Tower Hospital · CNTongji University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiation therapy (RT) has emerged as one of the most promising anti-tumor strategies for neuroblastoma. Nevertheless, the special tumor microenvironment (TME), including hypoxic and GSH-overexpressed TME, often greatly restricts the RT outcome. In this study, we demonstrated a dual-channel parallel radicals nanoamplifier (ATO@PAE-PEG-AS1411/Fe

Indexed as

Free radicalsNanoparticlesNeuroblastomaRadiosensitizationRadiotherapy

Identifiers

PMID37822451
PMCPMC10562674
OpenAlexW4387311461

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.